Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety (Q33514014)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

liver transplantation

1 reference

based on heuristic

inferred from title

cost–benefit analysis

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Alessandro Vitale

object named as

Alessandro Vitale

1

0 references

object named as

Umberto Cillo

8

0 references

object named as

Sara Lonardi

4

0 references

object named as

Patrizia Burra

6

0 references

author name string

Michael L Volk

2

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Davide Pastorelli

3

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Fabio Farinati

5

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Paolo Angeli

7

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

language of work or name

0 references

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

165-173

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

The model for end-stage liver disease comes of age.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Waiting list removal rates among patients with chronic and malignant liver diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Resection prior to liver transplantation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Treatment of HCC in patients awaiting liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Molecular targeted therapies in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

The price tag on progress--chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

21 January 2018

Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

7 January 2021

based on heuristic

inferred from DOI database lookup

Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

7 January 2021

based on heuristic

inferred from DOI database lookup

Carrier screening for cystic fibrosis: costs and clinical outcomes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

7 January 2021

based on heuristic

inferred from DOI database lookup

Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.23260

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HEP.23260

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33514014&oldid=1519464753"